These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9695727

  • 1. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
    Wakasugi H, Yano I, Ito T, Hashida T, Futami T, Nohara R, Sasayama S, Inui K.
    Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727
    [Abstract] [Full Text] [Related]

  • 2. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
    Okamura N, Hirai M, Tanigawara Y, Tanaka K, Yasuhara M, Ueda K, Komano T, Hori R.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
    [Abstract] [Full Text] [Related]

  • 3. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
    Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R.
    J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120
    [Abstract] [Full Text] [Related]

  • 4. Toxic digoxin-drug interactions: the major role of renal P-glycoprotein.
    Koren G, Woodland C, Ito S.
    Vet Hum Toxicol; 1998 Feb; 40(1):45-6. PubMed ID: 9467211
    [Abstract] [Full Text] [Related]

  • 5. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
    Rengelshausen J, Göggelmann C, Burhenne J, Riedel KD, Ludwig J, Weiss J, Mikus G, Walter-Sack I, Haefeli WE.
    Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.
    Verschraagen M, Koks CH, Schellens JH, Beijnen JH.
    Pharmacol Res; 1999 Oct; 40(4):301-6. PubMed ID: 10527640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clarithromycin-induced digoxin toxicity: a case report and a review of the literature.
    Xu H, Rashkow A.
    Conn Med; 2001 Sep; 65(9):527-9. PubMed ID: 11678058
    [Abstract] [Full Text] [Related]

  • 12. Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literature.
    Lee CY, Marcotte F, Giraldeau G, Koren G, Juneau M, Tardif JC.
    Can J Cardiol; 2011 Sep; 27(6):870.e15-6. PubMed ID: 21907534
    [Abstract] [Full Text] [Related]

  • 13. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.
    Westphal K, Weinbrenner A, Zschiesche M, Franke G, Knoke M, Oertel R, Fritz P, von Richter O, Warzok R, Hachenberg T, Kauffmann HM, Schrenk D, Terhaag B, Kroemer HK, Siegmund W.
    Clin Pharmacol Ther; 2000 Oct; 68(4):345-55. PubMed ID: 11061574
    [Abstract] [Full Text] [Related]

  • 14. Two cases of clarithromycin-induced digoxin toxicity.
    Guerriero SE, Ehrenpreis E, Gallagher KL.
    Pharmacotherapy; 1997 Oct; 17(5):1035-7. PubMed ID: 9324195
    [Abstract] [Full Text] [Related]

  • 15. The digoxin-propafenone interaction: characterization of a mechanism using renal tubular cell monolayers.
    Woodland C, Verjee Z, Giesbrecht E, Koren G, Ito S.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):39-45. PubMed ID: 9336306
    [Abstract] [Full Text] [Related]

  • 16. Changes in the pharmacokinetics of digoxin in polyuria in streptozotocin-induced diabetic mice and lithium carbonate-treated mice.
    Ikarashi N, Kagami M, Kobayashi Y, Ishii M, Toda T, Ochiai W, Sugiyama K.
    Xenobiotica; 2011 Jun; 41(6):486-93. PubMed ID: 21319957
    [Abstract] [Full Text] [Related]

  • 17. From bench to bedside: utilization of an in vitro model to predict potential drug-drug interactions in the kidney: the digoxin-mifepristone example.
    Woodland C, Koren G, Ito S.
    J Clin Pharmacol; 2003 Jul; 43(7):743-50. PubMed ID: 12856388
    [Abstract] [Full Text] [Related]

  • 18. Itraconazole decreases renal clearance of digoxin.
    Jalava KM, Partanen J, Neuvonen PJ.
    Ther Drug Monit; 1997 Dec; 19(6):609-13. PubMed ID: 9421099
    [Abstract] [Full Text] [Related]

  • 19. Effect of grapefruit juice on digoxin pharmacokinetics in humans.
    Becquemont L, Verstuyft C, Kerb R, Brinkmann U, Lebot M, Jaillon P, Funck-Brentano C.
    Clin Pharmacol Ther; 2001 Oct; 70(4):311-6. PubMed ID: 11673746
    [Abstract] [Full Text] [Related]

  • 20. The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers.
    Tsutsumi K, Kotegawa T, Kuranari M, Otani Y, Morimoto T, Matsuki S, Nakano S.
    J Clin Pharmacol; 2002 Oct; 42(10):1159-64. PubMed ID: 12362931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.